DE69834194T2 - Oberfläche-exponierte proteine von chlamydia pneumoniae - Google Patents
Oberfläche-exponierte proteine von chlamydia pneumoniae Download PDFInfo
- Publication number
- DE69834194T2 DE69834194T2 DE69834194T DE69834194T DE69834194T2 DE 69834194 T2 DE69834194 T2 DE 69834194T2 DE 69834194 T DE69834194 T DE 69834194T DE 69834194 T DE69834194 T DE 69834194T DE 69834194 T2 DE69834194 T2 DE 69834194T2
- Authority
- DE
- Germany
- Prior art keywords
- seq
- proteins
- pneumoniae
- protein
- kda
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Gram-negative bacteria
- C07K16/125—Gram-negative bacteria from Chlamydiales (O)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK74497 | 1997-06-23 | ||
| DK74497 | 1997-06-23 | ||
| PCT/DK1998/000266 WO1998058953A2 (en) | 1997-06-23 | 1998-06-19 | Surface exposed proteins from chlamydia pneumoniae |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69834194D1 DE69834194D1 (de) | 2006-05-24 |
| DE69834194T2 true DE69834194T2 (de) | 2007-03-29 |
Family
ID=8097044
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69834194T Expired - Lifetime DE69834194T2 (de) | 1997-06-23 | 1998-06-19 | Oberfläche-exponierte proteine von chlamydia pneumoniae |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US7264941B1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP1007685B1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP4160640B2 (cg-RX-API-DMAC10.html) |
| CN (1) | CN1249233C (cg-RX-API-DMAC10.html) |
| AT (1) | ATE323164T1 (cg-RX-API-DMAC10.html) |
| AU (1) | AU749382B2 (cg-RX-API-DMAC10.html) |
| BR (1) | BR9810288A (cg-RX-API-DMAC10.html) |
| CA (1) | CA2294651A1 (cg-RX-API-DMAC10.html) |
| DE (1) | DE69834194T2 (cg-RX-API-DMAC10.html) |
| DK (1) | DK1007685T3 (cg-RX-API-DMAC10.html) |
| ES (1) | ES2264810T3 (cg-RX-API-DMAC10.html) |
| PT (1) | PT1007685E (cg-RX-API-DMAC10.html) |
| WO (1) | WO1998058953A2 (cg-RX-API-DMAC10.html) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6710033B1 (en) | 1996-08-14 | 2004-03-23 | Vanderbilt University | Methods and treatment of multiple sclerosis |
| US6890526B2 (en) | 1997-05-06 | 2005-05-10 | Vanderbilt University | Methods and reagents for the treatment of multiple sclerosis |
| US6649370B1 (en) * | 1998-10-28 | 2003-11-18 | Aventis Pasteur Limited | Chlamydia antigens and corresponding DNA fragments and uses thereof |
| EP1129202A2 (en) * | 1998-10-28 | 2001-09-05 | Aventis Pasteur Limited | Chlamydia antigenes and corresponding dna fragments and uses thereof |
| US6872814B2 (en) * | 1998-10-29 | 2005-03-29 | Aventis Pasteur Limited | Chlamydia antigens and corresponding DNA fragments and uses thereof |
| NZ512308A (en) * | 1998-12-01 | 2004-01-30 | Aventis Pasteur | Chlamydia antigens and corresponding DNA fragments and uses thereof |
| AU3790900A (en) | 1998-12-01 | 2000-06-19 | Aventis Pasteur Limited | Chlamydia antigens and corresponding DNA fragments and uses thereof |
| EP2172214A3 (en) | 1999-03-12 | 2011-03-16 | Aventis Pasteur Limited | Chlamydia antigens and corresponding DNA fragments and uses thereof |
| WO2000066739A2 (en) * | 1999-05-03 | 2000-11-09 | Aventis Pasteur Limited | Chlamydia antigens and corresponding dna fragments and uses thereof |
| CA2385325C (en) * | 1999-09-20 | 2012-04-10 | Aventis Pasteur Limited | Chlamydia antigens and corresponding dna fragments and uses thereof |
| US20010048927A1 (en) | 2000-02-01 | 2001-12-06 | Richard Stephens | Porin B (PorB) as a therapeutic target for prevention and treatment of infection by chlamydia |
| ATE440861T1 (de) * | 2000-07-03 | 2009-09-15 | Novartis Vaccines & Diagnostic | Immunisierung gegen chlamydia pneumoniae |
| US7105171B2 (en) | 2002-03-07 | 2006-09-12 | The Regents Of The University Of California | Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia |
| EP3452197A4 (en) | 2016-05-04 | 2020-01-22 | Children's Hospital & Research Center at Oakland | FAST EXTRACTION OF NUCLEIC ACIDS FROM CLINICAL SAMPLES FOR DOWNSTREAM APPLICATIONS |
| US20220221456A1 (en) * | 2019-05-06 | 2022-07-14 | Arocell Ab | Respiratory infection detection and classification |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU692889B2 (en) * | 1994-08-03 | 1998-06-18 | Hitachi Chemical Company, Ltd. | Monoclonal antibodies having a reactivity specific to Chlamydia pneumoniae, method for production of the monoclonal antibodies, such antibody producing cells, method for production of the cells, method for detection and/or measurement of Chlamydia pneumoniae, reagents for the method, method and agents for diagnosis of chlamydia pneumoniae infection |
| CN100365017C (zh) | 1994-09-20 | 2008-01-30 | 日立化成工业株式会社 | 肺炎衣原体抗原多肽 |
| US6248329B1 (en) * | 1998-06-01 | 2001-06-19 | Ramaswamy Chandrashekar | Parasitic helminth cuticlin nucleic acid molecules and uses thereof |
-
1998
- 1998-06-19 ES ES98928179T patent/ES2264810T3/es not_active Expired - Lifetime
- 1998-06-19 DE DE69834194T patent/DE69834194T2/de not_active Expired - Lifetime
- 1998-06-19 JP JP50361399A patent/JP4160640B2/ja not_active Expired - Fee Related
- 1998-06-19 AT AT98928179T patent/ATE323164T1/de not_active IP Right Cessation
- 1998-06-19 DK DK98928179T patent/DK1007685T3/da active
- 1998-06-19 AU AU80119/98A patent/AU749382B2/en not_active Ceased
- 1998-06-19 US US09/446,677 patent/US7264941B1/en not_active Expired - Fee Related
- 1998-06-19 WO PCT/DK1998/000266 patent/WO1998058953A2/en not_active Ceased
- 1998-06-19 PT PT98928179T patent/PT1007685E/pt unknown
- 1998-06-19 CA CA002294651A patent/CA2294651A1/en not_active Abandoned
- 1998-06-19 EP EP98928179A patent/EP1007685B1/en not_active Expired - Lifetime
- 1998-06-19 BR BR9810288-5A patent/BR9810288A/pt not_active Application Discontinuation
- 1998-06-19 CN CNB988064286A patent/CN1249233C/zh not_active Expired - Fee Related
-
2007
- 2007-07-12 US US11/826,125 patent/US20080226679A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| ATE323164T1 (de) | 2006-04-15 |
| US20080226679A1 (en) | 2008-09-18 |
| JP2002510970A (ja) | 2002-04-09 |
| EP1007685A2 (en) | 2000-06-14 |
| ES2264810T3 (es) | 2007-01-16 |
| WO1998058953A2 (en) | 1998-12-30 |
| AU749382B2 (en) | 2002-06-27 |
| PT1007685E (pt) | 2006-08-31 |
| AU8011998A (en) | 1999-01-04 |
| DK1007685T3 (da) | 2006-08-14 |
| WO1998058953A3 (en) | 1999-03-18 |
| US7264941B1 (en) | 2007-09-04 |
| DE69834194D1 (de) | 2006-05-24 |
| CN1249233C (zh) | 2006-04-05 |
| BR9810288A (pt) | 2000-09-19 |
| CN1261403A (zh) | 2000-07-26 |
| EP1007685B1 (en) | 2006-04-12 |
| JP4160640B2 (ja) | 2008-10-01 |
| CA2294651A1 (en) | 1998-12-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69232956T2 (de) | Verbesserungen der diagnose und der prophylaxe von borrelia burgdorferi | |
| EP0643974B1 (de) | Impfstoff gegen die Lyme-Krankheit | |
| EP0506868B2 (de) | Immunologisch aktive proteine von borrelia burgdorferi, zusammenhängende testkits und impfstoff | |
| DE69632625T2 (de) | Mykrobakterielle proteine, mikroorganismen welche diese produzieren und ihre verwendung als impfstoff und zum nachweis von zuberkulose | |
| DE69333802T2 (de) | Äusseres membranprotein von haemophilus | |
| DE69630457T2 (de) | Verbindungen zur immunotherapie und diagnose von tuberkulose | |
| DE69434681T2 (de) | VAKZINE FÜR -i(BRANHAMELLA CATARRHALIS) | |
| DE69333585T2 (de) | Gereinigtes vakuolisierendes toxin aus helicobacter pylori und methoden zu dessen verwendung | |
| DE69735715T2 (de) | Cholin-bindendes Protein, welches als gegen Pneumokokken gerichtetes Vakzin verwendet wird | |
| DE60036698T2 (de) | Chlamydia-antigene und entsprechende dna-fragmente und deren verwendungen | |
| DE60037900T2 (de) | Chlamydia antigene und entsprechende dna-fragmente und ihre verwendungen | |
| US20080226679A1 (en) | Novel surface exposed proteins from chlamydia pneumoniae | |
| DE60120621T2 (de) | Lawsonia intracellularis Impfstoff | |
| DE69016129T2 (de) | Vakzin gegen Escherichia coli. | |
| DE69930166T2 (de) | Verfahren und zusammensetzungen für impfung mit dem pseudomonas aeruginosa v-antigen | |
| DE69835682T2 (de) | Oberflächenantigene und proteine für zusammensetzungen zu diagnose und vorbeugung der lyme-kkrankheit | |
| DE3650571T2 (de) | Hauptprotein der Aussenmembran von Chlamydia | |
| DE69419966T2 (de) | Impstoff gegen Streptococcus suis-Infektion | |
| DE69214277T2 (de) | Dna-sequenzen, die für die virulente eigenschaft von -i(streptococcus suis) kodieren, und teile davon, polypeptide und antikörper die sich davon ableiten und deren verwendung für diagnose und prophylaxe der infektion mit streptococcus suis in säugetieren, insbesondere in menschen | |
| DE3856240T2 (de) | Herstellung der p1 proteine und impfstoffe gegen gonorrhöe | |
| DE69232483T2 (de) | Mycobacteriumprotein und dessen verwendung | |
| DE69333560T2 (de) | Transport und expression eines hybriden oberflächenproteins an der oberfläche von grampositiven bakterien | |
| DE69133276T2 (de) | Mit der familie der hämolysin-toxine verwandte antigene eisen-ubnterdrückende proteine des n. meningitis | |
| DE68916424T2 (de) | Pasteurella-impfstoff. | |
| DE69331377T2 (de) | Verfahren und zusammensetzungen zur diagnose der katzenkratzkrankheit und der bakteriellen angiomatose |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |